Morgan Stanley’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,229
Closed -$101K 8204
2022
Q1
$101K Sell
10,229
-4,728
-32% -$46.4K ﹤0.01% 6306
2021
Q4
$146K Sell
14,957
-10,248
-41% -$100K ﹤0.01% 6231
2021
Q3
$247K Sell
25,205
-69,841
-73% -$684K ﹤0.01% 5888
2021
Q2
$951K Sell
95,046
-182,250
-66% -$1.86M ﹤0.01% 5106
2021
Q1
$2.83M Buy
+277,296
New +$3.28M ﹤0.01% 3982

Other funds holding HAAC

Morgan Stanley's HAAC Position: Q2 2022 in Review

Morgan Stanley sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q2 2022, closing a stake of 10,229 shares — an estimated $101K sold.

Morgan Stanley first reported a position in HAAC in Q1 2021 and held it in 5 quarters. The position peaked at $2.83M in Q1 2021. 86 funds tracked by Wall St. Rank hold HAAC as of Q2 2022.

  • Morgan Stanley reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Morgan Stanley sold 10,229 Health Assurance Acquisition Corp. Class A Common Stock shares in Q2 2022, an estimated $101K.
  • Morgan Stanley first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 5 quarters.
  • Morgan Stanley's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $2.83M in Q1 2021.
  • 86 funds tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.